Literature DB >> 15730987

Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas.

S-A Yeh1, J-T Ho, C-C Lui, Y-J Huang, C-Y Hsiung, E-Y Huang.   

Abstract

Low-grade gliomas account for 10-15% of all adult primary intracranial tumours. Currently, there is no consensus on the treatment strategy for low-grade gliomas. This study was designed to evaluate the treatment outcomes, prognostic factors and radiation-related late complications, as well as to assess whether or not post-operative radiotherapy has benefit on local control and overall survival in this population. We retrospectively reviewed 93 consecutive adult patients with supratentorial low-grade gliomas diagnosed at our institution from July 1985 to December 1997. All patients underwent surgical intervention and 60 of them received post-operative radiotherapy. With a median follow-up of 110 months for surviving patients, the 5-year overall and progression-free survival rates were 57% and 47%, respectively. 46 patients experienced local progression of disease during the follow-up period. In multivariate analysis, age at diagnosis, extent of surgery and post-operative Karnofsky performance status showed independent prognostic significance for progression-free and overall survival rates. Post-operative radiotherapy had independent prognostic value for progression-free survival. This analysis has changed our practice and we suggest that aggressive surgical resection and post-operative radiotherapy might be considered for patients with low-grade gliomas. Further efforts should be made to optimize radiotherapy techniques and to integrate new therapeutic modalities.

Entities:  

Mesh:

Year:  2005        PMID: 15730987     DOI: 10.1259/bjr/28534346

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  43 in total

1.  Imaging Advances in Stereotactic Radiosurgery.

Authors:  Christina Tsien; Robert E Drzymala; Keith Rich
Journal:  Mo Med       Date:  2015 Sep-Oct

2.  A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.

Authors:  Makoto Ideguchi; Takafumi Nishizaki; Norio Ikeda; Tomomi Okamura; Yasue Tanaka; Natsumi Fujii; Machiko Ohno; Taichi Shimabukuro; Tokuhiro Kimura; Eiji Ikeda; Kazuyoshi Suga
Journal:  J Neurooncol       Date:  2018-03-07       Impact factor: 4.130

3.  Exercise interest and preferences among patients diagnosed with primary brain cancer.

Authors:  Lee W Jones; Bebe Guill; Stephen T Keir; Karen Carter; Henry S Friedman; Darell D Bigner; David A Reardon
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

Review 4.  Operative techniques for gliomas and the value of extent of resection.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Interstitial imaging with multiple diffusive reflectance spectroscopy projections for in vivo blood vessels detection during brain needle biopsy procedures.

Authors:  Fabien Picot; Andréanne Goyette; Sami Obaid; Joannie Desroches; Simon Lessard; Marie-André Tremblay; Mathias Strupler; Brian Wilson; Kevin Petrecca; Gilles Soulez; Frédéric Leblond
Journal:  Neurophotonics       Date:  2019-04-23       Impact factor: 3.593

6.  Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping.

Authors:  Emmanuel Mandonnet; Saad Jbabdi; Luc Taillandier; Damien Galanaud; Habib Benali; Laurent Capelle; Hugues Duffau
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

Review 7.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Authors:  Hugues Duffau; Luc Taillandier
Journal:  Neuro Oncol       Date:  2014-08-02       Impact factor: 12.300

Review 8.  Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

Authors:  A Brodbelt
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

9.  Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Authors:  Barbara J Fisher; Chen Hu; David R Macdonald; Glenn J Lesser; Stephen W Coons; David G Brachman; Samuel Ryu; Maria Werner-Wasik; Jean-Paul Bahary; Junfeng Liu; Arnab Chakravarti; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-01-30       Impact factor: 7.038

Review 10.  Low-grade gliomas.

Authors:  Jimmy Ruiz; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2009-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.